Evaluating the Clinical Outcomes of Drug-Coated Balloon and Conventional Balloon Angioplasty in the Management of Stent Edge Restenosis

Abstract

Background Coronary stenting is frequently complicated by stent edge restenosis (SER), which causes the artery to re-narrow. Drug-eluting stents (DES), plain balloon angioplasty (POBA), conventional balloon angioplasty (CBA), and drug-coated balloons (DCBs) are possible treatments for SER. Methods This study compared the effectiveness of DCB angioplasty with CBA to treat SER. Eighty patients were randomly assigned to receive either DCB or CBA. At 8th week and 6 months, the primary patency of the target lesion and access circuits were assessed as clinical outcomes. Furthermore, levels of perceived stress were measured by perceived stress scores. Results At 8th week, the perceived stress levels of the DCB group were statistically significantly (<0.05) lower than those of the CBA group. Compared to the CBA group, the DCB group experienced improved outcomes at 6 months in all clinical outcomes. Conclusion DCB angioplasty may be superior to CBA in treating SER. In addition to enhancing vascular access, DCB angioplasty may also enhance mental and general well-being. Keywords Anxiety, Depression, Drug-Coated Balloon Vascular Access, Perceived Stress.